Total Costs & Expenses

$162.04M

TTM · Period ending: Jun 30, 2026 · USD

HRTX Total Costs & Expenses

Latest reported$162.04Mperiod endingJun 30, 2026

HRTX TTM Total Costs & Expenses (-$5.80M → $162.04M)

TTM Total Costs & Expenses

High-resolution chart · PNG

HRTX total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Heron Therapeutics Inc Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period ending	Total Costs & Expenses (USD)
Jun 30, 2026	162,042,000
Mar 31, 2026	161,169,000
Dec 31, 2025	157,442,000
Sep 30, 2025	153,500,000
Jun 30, 2025	148,462,000
Mar 31, 2025	152,094,000
Dec 31, 2024	155,813,000
Sep 30, 2024	163,658,000
Jun 30, 2024	182,753,000
Mar 31, 2024	214,449,000
Dec 31, 2023	237,659,000
Sep 30, 2023	243,589,000
Jun 30, 2023	255,665,000
Mar 31, 2023	258,628,000
Dec 31, 2022	282,330,000
Sep 30, 2022	306,139,000
Jun 30, 2022	312,638,000
Mar 31, 2022	318,422,000
Dec 31, 2021	304,174,000
Sep 30, 2021	311,883,000
Jun 30, 2021	315,294,000
Mar 31, 2021	310,799,000
Dec 31, 2020	316,801,000
Sep 30, 2020	329,345,000
Jun 30, 2020	328,473,000
Mar 31, 2020	338,494,000
Dec 31, 2019	356,662,000
Sep 30, 2019	342,375,000
Jun 30, 2019	326,464,000
Mar 31, 2019	294,156,000
Dec 31, 2018	261,411,000
Sep 30, 2018	253,196,000
Jun 30, 2018	241,516,000
Mar 31, 2018	235,951,000
Dec 31, 2017	225,325,000
Sep 30, 2017	201,464,000
Jun 30, 2017	199,312,000
Mar 31, 2017	191,813,000
Dec 31, 2016	172,194,000
Sep 30, 2016	155,172,000
Jun 30, 2016	129,929,000
Mar 31, 2016	109,877,000
Dec 31, 2015	96,925,000
Sep 30, 2015	85,360,000
Jun 30, 2015	81,822,000
Mar 31, 2015	77,599,000
Dec 31, 2014	74,561,000
Sep 30, 2014	68,898,000
Jun 30, 2014	62,609,000
Mar 31, 2014	59,027,000
Dec 31, 2013	54,457,000
Sep 30, 2013	49,253,000
Jun 30, 2013	42,643,000
Mar 31, 2013	31,814,000
Dec 31, 2012	23,831,000
Sep 30, 2012	19,321,000
Jun 30, 2012	17,356,000
Mar 31, 2012	14,767,000
Dec 31, 2011	11,708,000
Sep 30, 2011	9,502,000
Jun 30, 2011	7,399,000
Mar 31, 2011	9,833,000
Dec 31, 2010	11,235,000
Sep 30, 2010	11,545,000
Jun 30, 2010	11,889,000
Mar 31, 2010	11,638,000
Dec 31, 2009	11,503,000
Sep 30, 2009	13,133,000
Jun 30, 2009	17,144,000
Mar 31, 2009	19,571,000
Dec 31, 2008	23,814,000
Sep 30, 2008	27,910,000
Jun 30, 2008	26,926,000
Mar 31, 2008	25,160,000
Dec 31, 2007	24,090,000
Sep 30, 2007	21,868,000
Jun 30, 2007	20,459,000
Mar 31, 2007	20,613,000
Dec 31, 2006	18,864,000
Sep 30, 2006	17,257,000
Jun 30, 2006	16,483,000
Mar 31, 2006	15,595,000
Dec 31, 2005	13,865,000
Sep 30, 2005	13,566,000
Jun 30, 2005	13,808,000
Mar 31, 2005	13,632,000
Dec 31, 2004	14,720,000
Sep 30, 2004	13,776,000
Jun 30, 2004	12,863,000
Mar 31, 2004	12,239,000
Dec 31, 2003	11,460,000
Sep 30, 2003	11,072,000
Jun 30, 2003	11,356,000
Mar 31, 2003	11,172,000
Dec 31, 2002	10,449,000
Sep 30, 2002	11,344,000
Jun 30, 2002	11,458,000
Mar 31, 2002	11,063,000
Dec 31, 2001	11,090,000
Sep 30, 2001	10,341,000